Chapter 12 Current management of hormone-refractory prostate cancer
Author:
Publisher
Elsevier
Reference75 articles.
1. Prognostic factors in patients with prostate cancer refractory to endocrine therapy: Univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase;Akimoto;Jpn. J. Clin. Oncol.,1997
2. Preliminary results of a phase II trial of estramustine and vinblastine for patients with progressive hormone refractory prostate cancer;Amato,1991
3. Complete remission of hormone refractory adenocarcinoma of the prostate in response to withdrawal of diethylstilbestrol;Bissada;J. Urol.,1995
4. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone resistant prostate cancer based on a Canadian randomized trial with palliative endpoints;Bloomfield,1997
5. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS related complex: Clinical pharmacology and suppression of virus replication in vitro;Broder;Lancet,1985
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3